Kineta Inc.
Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (m… Read more
Kineta Inc. (KA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.153x
Based on the latest financial reports, Kineta Inc. (KA) has a cash flow conversion efficiency ratio of 0.153x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.22 Million) by net assets ($-7.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kineta Inc. - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Kineta Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kineta Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kineta Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Megapolitan Developments Tbk
JK:EMDE
|
-0.004x |
|
Sahathai Terminal Public Company Limited
BK:PORT
|
0.073x |
|
ADV. SOLTEC.SWE. AB 10/21
F:7ST0
|
N/A |
|
Hultström Group B
ST:HULT-B
|
0.156x |
|
Group 6 Metals Ltd
AU:G6M
|
0.200x |
|
Venari Minerals NL
AU:VMS
|
-0.021x |
|
Saigon Garment Manufacturing Trade JSC
VN:GMC
|
N/A |
|
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC
|
-0.205x |
Annual Cash Flow Conversion Efficiency for Kineta Inc. (2019–2023)
The table below shows the annual cash flow conversion efficiency of Kineta Inc. from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $3.06 Million | $-16.21 Million | -5.299x | -27.26% |
| 2022-12-31 | $4.57 Million | $-19.03 Million | -4.164x | -378.69% |
| 2021-12-31 | $-11.95 Million | $-17.85 Million | 1.494x | +1502.09% |
| 2020-12-31 | $-21.55 Million | $2.30 Million | -0.107x | +87.26% |
| 2019-12-31 | $62.38 Million | $-52.17 Million | -0.836x | -- |